About the Authors
- Tomohiro Kawahara
-
* E-mail: kawahara_tomohiro@biofermin.co.jp
Affiliation R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Yutaka Makizaki
-
Affiliation R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Yosuke Oikawa
-
Affiliation R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Yoshiki Tanaka
-
Affiliation R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Ayako Maeda
-
Affiliation R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Masaki Shimakawa
-
Affiliation R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Satoshi Komoto
-
Affiliation Department of Virology and Parasitology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
- Kyoko Moriguchi
-
Affiliation Department of Virology and Parasitology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
- Hiroshi Ohno
-
Affiliation R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Koki Taniguchi
-
Affiliation Department of Virology and Parasitology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
Competing Interests
This study was funded by Biofermin Pharmaceutical Co., Ltd. Authors [TK, YM, YO, YT, AM, MS and HO] are employees of Biofermin Pharmaceutical Co., Ltd. Author [KT] received a Grant-in-Aid from Biofermin Pharmaceutical Co., Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: TK MS HO KT. Data curation: TK YM YO AM. Formal analysis: TK YT AM. Funding acquisition: KT. Investigation: TK YM YO YT AM. Methodology: TK YT MS HO KT. Project administration: MS HO KT. Resources: TK SK KM KT. Supervision: MS HO KT. Validation: MS HO KT. Visualization: TK HO KT. Writing – original draft: TK. Writing – review & editing: TK KT.